1 Acro Biomedical Co Ltd Receivables Turnover Ratio (ACBM), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Competitors, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Acro Biomedical Co Ltd (ACBM)

Sector • Services Industry • Movies and Entertainment

Industry • Movies and Entertainment

Sector • Services

Acro Biomedical Co Ltd Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics

According to Acro Biomedical Co Ltd Balance Sheet, in the first quarter 2026, company has not reported any Accounts receivable.
See Acro Biomedical Co Ltd Balance Sheet

If we take a look into Services sector Acro Biomedical Co Ltd achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Acro Biomedical Co Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACBM Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	-	-	-	-	-
ACBM's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Movies and Entertainment Industry	#
Services Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

ACBM Company Profile • Back to ACBM Efficiency Comparisons • Compare ACBM Receivables Turnover Ratio to its Competitors

Financial Statements
Acro Biomedical Co Ltd 's Accounts Receivable	$ 0 Millions	Visit ACBM's Balance sheet
Acro Biomedical Co Ltd 's Sales TTM	$ 0 Millions	Visit ACBM's Income Statement
Sources of ACBM's Revenues		Visit ACBM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Movies and Entertainment Industry Accounts Receivable Turnover Trends and Statistics
Services Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACBM's Receivable Turnover Ratio versus Movies and Entertainment Industry, Services Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACBM's Growth Rates	ACBM's Roa	ACBM's Inventory Turnover Ratio	ACBM's Dividend Comparisons
ACBM's Profitability Ratios	ACBM's Roi	ACBM's Asset Turnover Ratio	ACBM's Dividend Growth
ACBM's Valuation Ratios	ACBM's Roe	ACBM's Financial Strength Ratios	ACBM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Services Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2026

Receivable at quarter ending Mar 31 2026

Date modified: 2026-05-06T06:51:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.